Sector
PharmaceuticalsOpen
₹42.29Prev. Close
₹42.29Turnover(Lac.)
₹4Day's High
₹43.62Day's Low
₹42.2952 Week's High
₹73.952 Week's Low
₹37.16Book Value
₹14.16Face Value
₹10Mkt Cap (₹ Cr.)
171.81P/E
0EPS
0Divi. Yield
028 Oct 2024
12:00 AM
Board Meeting
Agenda : Audited Result
2 Jul 2024
12:00 AM
AGM
Announcement Date: 02 Jul, 2024
2 Jul 2024
12:00 AM
BookCloser
22 Sep 2023
12:00 AM
Rights
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 39.86 | 31.89 | 24.18 | 21.66 |
Preference Capital | 0 | 0 | 0 | 1 |
Reserves | 17.09 | -9.59 | -17.24 | -15.54 |
Net Worth | 56.95 | 22.3 | 6.94 | 7.12 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 68.49 | 76.92 | 93.1 | 66.51 |
yoy growth (%) | -10.95 | -17.38 | 39.98 | 430.71 |
Raw materials | -60.85 | -68.43 | -83.32 | -58.26 |
As % of sales | 88.85 | 88.96 | 89.49 | 87.59 |
Employee costs | -4.09 | -2.99 | -2.95 | -2.46 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -7.31 | -2.2 | 1.5 | 0.78 |
Depreciation | -2.35 | -2.14 | -2.14 | -2.08 |
Tax paid | 1.74 | 0.34 | -0.75 | -0.26 |
Working capital | 8.78 | -2.03 | 0.93 | 1.09 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -10.95 | -17.38 | 39.98 | 430.71 |
Op profit growth | 4,105.46 | -103.42 | 18.48 | -5,852.57 |
EBIT growth | 232.63 | -244.05 | 61.23 | -144.62 |
Net profit growth | 200.35 | -346.29 | 123.06 | -122.69 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,804.8 | 157.5 | 4,34,195.65 | 863.29 | 0.75 | 5,123.67 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,130.1 | 88.09 | 1,61,829.65 | 518 | 0.49 | 2,302 | 513.62 |
Cipla Ltd CIPLA | 1,477.6 | 28.59 | 1,21,053.04 | 1,178.16 | 0.87 | 3,969.86 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,332.25 | 69.57 | 1,13,812.4 | 460 | 0.83 | 2,376 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,585.1 | 52.35 | 1,04,937.42 | 634.43 | 0 | 2,529.74 | 269.23 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Director & MD
Ranjan Jain
E D & Wholetime Director
Suninder Veer Singh
Independent Non Exe. Director
Arshdeep Kaur
Non-Exec & Non-Independent Dir
Neena Batra
Independent Non Exe. Director
Renu Rawat
Company Sec. & Compli. Officer
Shikha Kataria
Non Executive Director
Vivek Trehan
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Syschem (India) Ltd
Summary
Syschem (India) Limited formerly known as Anil Pesticides Limited was incorporated in 1993 and promoted by Anil Nibber, Atul Nibber and Ajay Kumar Singla. The Company is engaged in the business of manufacturing of API / Intermediates. It has its manufacturing facility at Village Bargodam, Tehsil Kalka, Distt. Panchkula (Haryana).In 1996 the company went for launching new product called Monocrotophos and production was commisioned on 1998 only.The company expanded the installed capacity of Dichlorvos by 400 TPM in 2000.The company introduced new products namely Deta,DETC and Ethion in 2001. It is also planning for diversification plan by manufacturing new range of chemicals of compounds for various applications.The Company started commercial production of 7-ADCA key Drug Intermediate for Cephalosporin family of Bulk Drugs during year 2003-04. It added 2 new products like Fexa Fenadine Intermediate and THF during 2010. The Company changed its product line from Chemical manufacturing to Pharmaceutical Industry during the Financial Year 2017-2018.
Read More
What is the Syschem India Ltd share price today?
The Syschem India Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹43.1 today.
What is the Market Cap of Syschem India Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Syschem India Ltd is ₹171.81 Cr. as of 06 Dec ‘24
What is the PE and PB ratio of Syschem India Ltd?
The PE and PB ratios of Syschem India Ltd is 0 and 2.99 as of 06 Dec ‘24
What is the 52 Week High and Low of Syschem India Ltd?
The 52-week high/low is the highest and lowest price at which a Syschem India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Syschem India Ltd is ₹37.16 and ₹73.9 as of 06 Dec ‘24
What is the CAGR of Syschem India Ltd?
Syschem India Ltd's CAGR for 5 Years at 47.54%, 3 Years at 51.72%, 1 Year at -20.30%, 6 Month at -8.70%, 3 Month at -14.18% and 1 Month at -8.11%.
What is the shareholding pattern of Syschem India Ltd?
The shareholding pattern of Syschem India Ltd is as follows:
Promoters - 53.17 %
Institutions - 0.20 %
Public - 46.63 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
